None listed
Conditions
Interventions
Medical Device : 1) acupuncture point: LI4, TE3,(four points bilateral) will be used for upper extremities neuropathy and LV3, GB41 (four points bilateral) will be used for lower extremities neuropat
Sponsors
Comprehensive and Integrative Medical Institute
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) History of histologically or cytologically proven cancer. 2) The Eastern Cooperative Oncology Group performance scale : 0-2 3) Symptoms occurred after chemotherapy 4) Patients who have experienced symptoms of chemotherapy induced peripheral neuropathy more than 1 month. 5) The NRS(numerical rating scale) is more than 4. 6) Patients who are able to complete questionnaires. 7) Patients who voluntarily agree to participate and sign the consent form themselves or the form is signed by their guardian 8) PAtients for whom follow-up observations are possible throughout the study period.
Exclusion criteria
Exclusion criteria: 1) Patients who have a heart disease and uncontrolled hypertension (more than 160/100 mmHg) 2) Uncontrolled diabetes (FBST=180, BST=250) 3) Patients who cannot be done an warm acupuncture because of wound of treatment area 4) History of neuropathy caused by diabetes or other diseases. 5) Patients using physical therapy, massage, acupuncture et al. for relieving symptoms of peripheral neuropathy. 6) Patients who are not suitable for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| European Organization for Research and Treatment of Cancer quality of life questionnaire to assess CIPN, NRS | — |
Secondary
| Measure | Time frame |
|---|---|
| M. D. Anderson symptom Inventory, European Organization for Research and Treatment of Cancer quality of life questionnaire version 3.0, Semmes-Weinstein Monofilament test | — |
Countries
Korea, Republic of
Contacts
Public ContactJung jung
Daegu Oriental Hospital of Daegu Haany University
Outcome results
None listed